These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10491880)

  • 1. Meningococcal disease in siblings caused by rifampicin sensitive and rifampicin resistant strains.
    Dawson SJ; Fey RE; McNulty CA
    Commun Dis Public Health; 1999 Sep; 2(3):215-6. PubMed ID: 10491880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in chemoprophylaxis for meningococcal disease: a retrospective case note review, analysis of routine prescribing data and questionnaire of general practitioners.
    Marks PJ; Neal KR
    BMC Public Health; 2001; 1():16. PubMed ID: 11806758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7.
    Cooke RP; Riordan T; Jones DM; Painter MJ
    BMJ; 1989 Mar; 298(6673):555-8. PubMed ID: 2495111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing secondary cases of meningococcal disease by identifying and eradicating disease-causing strains in close contacts of patients.
    Kristiansen BE; Tveten Y; Ask E; Reiten T; Knapskog AB; Steen-Johnsen J; Hopen G
    Scand J Infect Dis; 1992; 24(2):165-73. PubMed ID: 1641593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Meningococcal disease in 2 siblings--failure of rifampicin prophylaxis].
    Kolmos HJ; Grytter C; Lind I
    Ugeskr Laeger; 1987 Nov; 149(48):3267-8. PubMed ID: 3124322
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylaxis of contacts of patients with meningococcal infection.
    Gaebler JW; Kleiman MB; Reynolds JK; Allen SD; Smith JW
    J Indiana State Med Assoc; 1983 Dec; 76(12):828-30. PubMed ID: 6418826
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampin-resistant meningococcal infection in a patient given rifampin chemoprophylaxis.
    Berkey P; Rolston K; Zukiwski A; Gooch G; Bodey GP
    Am J Infect Control; 1988 Dec; 16(6):250-2. PubMed ID: 3144922
    [No Abstract]   [Full Text] [Related]  

  • 8. Meningococcal disease in a backpackers hostel in Scotland: a risk assessment for prophylaxis.
    Davis LC; Smith KA; Willocks LJ
    Euro Surveill; 2009 Aug; 14(31):. PubMed ID: 19660243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal disease in the Israel Defense Force: epidemiologic trends and new challenges.
    Grotto I; Block C; Lerman Y; Wiener M; Ashkenazi S
    Isr J Med Sci; 1995 Jan; 31(1):54-8. PubMed ID: 7836050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampin-resistant meningococcal disease.
    Rainbow J; Cebelinski E; Bartkus J; Glennen A; Boxrud D; Lynfield R
    Emerg Infect Dis; 2005 Jun; 11(6):977-9. PubMed ID: 15963302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary cases of meningococcal disease in The Netherlands, 1989-1990; a reappraisal of chemoprophylaxis].
    Scholten RJ; Bijlmer HA; Dankert J; Valkenburg HA
    Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1505-8. PubMed ID: 8366938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprophylaxis fails to prevent a second case of meningococcal disease in a day nursery.
    Cartwright KA; Hunt D; Fox A
    Commun Dis Rep CDR Rev; 1995 Dec; 5(13):R199. PubMed ID: 8556104
    [No Abstract]   [Full Text] [Related]  

  • 13. [Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
    Arreaza L; de la Fuente L; Fernández S; Vázquez JA
    Rev Esp Quimioter; 2000 Jun; 13(2):182-6. PubMed ID: 10918092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Feb; 46(RR-5):1-10. PubMed ID: 9048846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of the prescribing of chemoprophylaxis to index cases of invasive meningococcal disease.
    Heywood P; Holtby I
    Commun Dis Public Health; 2000 Dec; 3(4):271-3. PubMed ID: 11280257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal disease. Secondary attack rate and chemoprophylaxis in the United States, 1974.
    JAMA; 1976 Jan; 235(3):261-5. PubMed ID: 811822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chemoprophylaxis on the meningococcal carrier state after systemic infection.
    Alvez F; Aguilera A; Garcia-Zabarte A; Castro-Gago M
    Pediatr Infect Dis J; 1991 Sep; 10(9):700. PubMed ID: 1923684
    [No Abstract]   [Full Text] [Related]  

  • 18. Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999.
    Hansman D; Wati S; Lawrence A; Turnidge J
    Pathology; 2004 Apr; 36(2):160-5. PubMed ID: 15203752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meningococcal epidemic in a boarding school: a rifampicin-resistant secondary case while under chemoprophylaxis].
    Schubiger G; Munzinger J; Dudli C; Wipfli U
    Schweiz Med Wochenschr; 1986 Aug; 116(35):1172-5. PubMed ID: 3094142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cluster of four cases of meningococcal disease in a single nuclear family.
    Acheson P; Barron R; Borrow R; Gray S; Marodi C; Ramsay M; Waller J; Flood T
    Arch Dis Child; 2012 Mar; 97(3):248-9. PubMed ID: 22247241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.